While evidence from genetic studies, meta-analyses, and specific cardiovascular outcome trials (CVOTs) supports an association between certain GLP-1RAs and reduced AF risk, conflicting data exist regarding drug-specific effects, underscoring the need for further mechanistic and outcome research
Its not just about access
No, NAD+ is not Vitamin B3, though the two are similar
Endocrinol Metab 36:2229 Chudiwal V, Shahi S, Chudiwal S, Ahale D (2018) Innovative technologies for gastro-retentive drug delivery systems
Lilly also markets a tirzepatide treatment approved for type 2 diabetes under the brand name Mounjaro
A study found that while the drug is effective in weight management throughout therapy, discontinuing use will result in the patient regaining weight